Dr. Makker on Synergy Between Lenvatinib and Pembrolizumab in Endometrial Cancer
2 بازدیدها
administrator
09/30/23
Vicky Makker, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the synergy between lenvatinib and pembrolizumab in the treatment of patients with endometrial cancer.
بیشتر نشان بده، اطلاعات بیشتر
نظرات فیس بوک
نظری یافت نشد